Tissue resource for the development of gene therapy treatments

  • Research type

    Research Tissue Bank

  • IRAS ID

    155959

  • Contact name

    Claire Booth

  • Contact email

    c.booth@ucl.ac.uk

  • Research summary

    Tissue resource for development of gene therapy treatments (Gene Therapy Biobank)

  • REC name

    London - Queen Square Research Ethics Committee

  • REC reference

    14/LO/1494

  • Date of REC Opinion

    19 Jan 2015

  • REC opinion

    Further Information Favourable Opinion

  • Data collection arrangements

    We plan to collect primarily blood and bone marrow samples from patients with a genetic disease which may now, or
    in the future, be treated with gene or cellular therapies. We may also collect skin biopsies in order to create fibroblast
    cell lines for use in preclinical
    research. These samples will only be collected if the patient is undergoing either a
    clinically indicated blood test or procedure requiring anaesthetic when we would be able to take a bone marrow
    aspirate or skin biopsy without causing any distress or discomfort to the patient. These samples will then be
    processed and likely frozen until future use. Existing samples may exist from patients who fit the inclusion criteria and
    we will seek consent to use these samples.
    We anticipate collecting initially approximately 2030
    samples each year (inclusive of blood, bone marrow and skin
    biopsies). We anticipate using approximately 20 samples each year for experimental purposes. Data will be
    collected on the patients diagnosis and genetic mutation (if known) and this will be stored in a secure database
    accessed only by the tissue bank manager or those closely involved in the research projects.

  • Research programme

    We will be collecting samples from donors with inherited genetic conditions which are currently, or may in the future, be treated with gene or cellular therapies. These samples will be used in the preclinical development (more basic research) and clinical translation of such treatment strategies, for example in safety and efficacy studies allowing more rapid progression to Phase I/II clinical trials.

  • RTBTitle

    Tissue resource for development of gene therapy treatments (Gene Therapy Biobank)

  • Establishment organisation

    UCL Institute of Child Health

  • Establishment organisation address

    30 Guilford Street

    London

    WC1N 1EH